Finding 1074383 (2023-010)

Material Weakness Repeat Finding
Requirement
P
Questioned Costs
-
Year
2023
Accepted
2024-09-24

AI Summary

  • Core Issue: The organization failed to consistently maintain required records for federal awards, leading to compliance risks.
  • Impacted Requirements: This finding violates federal regulations (2 CFR 200.334) on document retention, which mandates keeping records for at least three years.
  • Recommended Follow-Up: Implement a robust document retention policy and engage a CPA consultant to ensure compliance with federal requirements.

Finding Text

#2023-010 – Major Federal Award Finding – Document Retention Nature of Finding: Compliance Finding – Uniform Guidance Administrative Requirements and Material Weakness in Internal Controls Over Compliance This is a repeat of prior year finding #2022-011. Criteria/Condition: Federal regulations 2 CFR 200.334 provides that a non-federal entity must retain all records pertinent to a federal award for a minimum period of three years from the date of submission of the annual financial report. We noted during testing that records were not consistently being maintained. Cause/Context: For 4 of the 40 expenditures selected for testing, the Organization was unable to provide appropriate invoice documentation supporting the amount charged to the grant. Effect: Federal expenditures could be charged to the grant at incorrect amounts or for unallowable costs. Recommendation: We recommend the Organization implement a document retention policy that is consistent with the federal document retention requirements. Views of Responsible Officials and Planned Corrective Actions: MARR will retain a CPA consultant to implement a document retention policy that is consistent with federal document retention requirements.

Categories

Allowable Costs / Cost Principles Material Weakness Matching / Level of Effort / Earmarking

Other Findings in this Audit

  • 497935 2023-004
    Material Weakness Repeat
  • 497936 2023-005
    Material Weakness Repeat
  • 497937 2023-006
    Material Weakness Repeat
  • 497938 2023-007
    Material Weakness Repeat
  • 497939 2023-008
    Material Weakness Repeat
  • 497940 2023-009
    Material Weakness Repeat
  • 497941 2023-010
    Material Weakness Repeat
  • 497942 2023-004
    Material Weakness Repeat
  • 497943 2023-005
    Material Weakness Repeat
  • 497944 2023-006
    Material Weakness Repeat
  • 497945 2023-007
    Material Weakness Repeat
  • 497946 2023-008
    Material Weakness Repeat
  • 497947 2023-009
    Material Weakness Repeat
  • 497948 2023-010
    Material Weakness Repeat
  • 1074377 2023-004
    Material Weakness Repeat
  • 1074378 2023-005
    Material Weakness Repeat
  • 1074379 2023-006
    Material Weakness Repeat
  • 1074380 2023-007
    Material Weakness Repeat
  • 1074381 2023-008
    Material Weakness Repeat
  • 1074382 2023-009
    Material Weakness Repeat
  • 1074384 2023-004
    Material Weakness Repeat
  • 1074385 2023-005
    Material Weakness Repeat
  • 1074386 2023-006
    Material Weakness Repeat
  • 1074387 2023-007
    Material Weakness Repeat
  • 1074388 2023-008
    Material Weakness Repeat
  • 1074389 2023-009
    Material Weakness Repeat
  • 1074390 2023-010
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.788 Opioid Str $117,344
93.959 Block Grants for Prevention and Treatment of Substance Abuse $35,139